First and Only REN-Based Migraine Treatment Approved in China

BEIJING and NETANYA, Israel, Sept. 29, 2025 /PRNewswire/ -- Pier 88 Health, a digital health company dedicated to reshaping chronic pain management and bringing breakthrough global medical innovations to Greater China, and Theranica, a prescribed digital therapeutics company, today announced that the Nerivio® REN wearable, a novel treatment of migraine, has received regulatory approval from China's National Medical Products Administration (NMPA).

The registration certificate (国械注进20252090343), issued on August 11, 2025, marks the first and only approval in China of a wearable migraine device using the Remote Electrical Neuromodulation (REN) technology. This drug-free, smartphone-controlled prescribed therapy provides a clinica

See Full Page